EVLA vs. Sclerotherapy: Which One Do I Need? A Doctor’s Guide

Table of Contents: 

• Introduction
• What is EVLA (Endovenous Laser Ablation)?
• What is Sclerotherapy?
• Comparison Chart (Easy Read for Patients)
• The “Combo” Approach: Why You Might Need Both
• Conclusion

1. Introduction

Many people who come for vein treatment have the same question in mind:

“Do I need laser, or can you just inject these veins and make them disappear?”

Terms like laser, ELVA/EVLA, sclerotherapy, spider veins and varicose veins get mixed up very easily. It is common for patients to assume that injections alone (sclerotherapy) can fix everything – from very fine spider veins on the ankle to large, rope-like varicose veins on the thigh. In reality, these are two different tools, used for different levels of the venous problem.

A useful way to think about this is the iceberg analogy. The veins you see on the surface – blue, green, red or bulging – are often just the visible tip. Underneath, there may be a larger vein with damaged valves (for example, the great saphenous vein) that allows blood to fall back down the leg instead of flowing smoothly upwards towards the heart. This backward flow, called venous reflux, increases pressure in the smaller surface veins and makes them dilate, twist and become more prominent over time.

If only the visible surface veins are treated while the deeper “leaking” vein is left alone, the cosmetic result usually does not last. An everyday comparison helps: treating only the visible spider veins without correcting the main valve leakage is like painting over a damp wall. The wall may look fresh for a short while, but if the pipe inside is still leaking, the damp patches will soon return. In the legs, the same thing happens – untreated reflux in the main vein keeps pushing high-pressure blood into the surface veins, and new spider or varicose veins appear again.

This leads to the golden rule in modern vein treatment:

First, treat the source of high pressure; then treat the surface for cosmetic refinement. In practical terms, that usually means using Endovenous Laser Ablation (EVLA) to close the faulty “trunk” vein that is causing reflux, and using sclerotherapy injections later to clear the remaining small veins and spider veins. The rest of this guide explains what EVLA is, what sclerotherapy is, how they differ, and why many legs actually need a planned combination of both rather than an either–or choice.

2. What is EVLA (Endovenous Laser Ablation)?

Endovenous Laser Ablation (often written as EVLA or ELVA) is a minimally invasive procedure used to treat faulty “trunk” veins in the leg – most commonly the great saphenous vein (GSV) or other large superficial veins that have valve failure and are causing varicose veins. These are the veins that run like main highways under the skin; when their valves stop working properly, blood flows backwards (refluxes) down the leg and creates high pressure in the smaller branches. EVLA is designed to switch off this diseased main vein from the inside, without the need for traditional vein stripping surgery.

Clinically, EVLA is best suited for large, bulging varicose veins that are fed by these main trunk veins. Spider veins and very small surface veins are usually too small for a laser fibre and are not the primary target of this technique. Instead, EVLA focuses on the “source” vein – the one that shows significant reflux on Doppler ultrasound, such as the great saphenous vein, small saphenous vein, or other incompetent tributaries.

From a technical standpoint, the procedure is performed under ultrasound guidance. After cleaning and numbing the skin, the doctor inserts a thin catheter into the faulty vein, often through a tiny needle puncture near the knee or lower leg. A fine laser fibre is passed through this catheter up to the area where the reflux begins (for example, near the groin where the GSV joins the deep system). Around the vein, a special local anaesthetic solution (tumescent anaesthesia) is injected to provide pain control, compress the vein around the fibre, and protect surrounding tissues from heat. The laser is then activated and slowly withdrawn along the vein. The heat from the laser damages the inner vein wall, causing it to collapse and seal shut. Over the following weeks to months, the body gradually fibroses and absorbs this closed vein.

For the patient, EVLA is typically a “walk-in, walk-out” day-care procedure. It is done under local anaesthesia (sometimes with mild sedation), does not require a surgical cut or stitches, and leaves only tiny puncture marks that usually heal with minimal scarring. Most people are encouraged to walk immediately after the procedure, wear a compression stocking for a period advised by the doctor, and resume light normal activities very quickly, while avoiding heavy exertion for a short time. Some common, short-term sensations include tightness or pulling along the treated vein, mild bruising, or local tenderness; these are expected and generally settle as healing progresses.

The medical reason for performing EVLA is to eliminate the backward flow (venous reflux) in the main diseased vein. By closing this vein, the abnormal high pressure transmitted to the branches and surface veins is reduced. This can improve symptoms such as heaviness, aching, swelling, night cramps, and skin changes, and it also helps to slow or prevent progression towards more serious complications like skin breakdown or venous ulcers. Importantly, closing the faulty superficial vein does not harm overall circulation because deeper, healthy veins take over the task of returning blood to the heart.

3. What is Sclerotherapy?

Sclerotherapy is a minimally invasive injection treatment used mainly for small surface veins in the legs. These include fine spider veins (telangiectasias), slightly larger reticular veins (the blue-green “feeder” veins under the skin), and residual small varicose veins or side branches that remain after the main faulty trunk vein has been treated (for example, after EVLA). It is not usually the first-line treatment for a large, straight trunk vein like the great saphenous vein in most standard cases, but it is extremely useful for finishing and refining the cosmetic result once the underlying reflux has been controlled.

In sclerotherapy, a special medicine called a sclerosant is injected directly into the abnormal vein using a very fine needle. Common sclerosants belong to classes such as detergent-type agents (for example, polidocanol or sodium tetradecyl sulfate) or osmotic/chemical agents, depending on local practice and regulations. These medicines are formulated to irritate and damage the inner lining (endothelium) of the vein wall. Once the sclerosant contacts the vein interior, it causes the wall to become inflamed, sticky, and then to collapse. Over time, the collapsed vein turns into a thin fibrous cord and is gradually broken down and absorbed by the body. Blood that previously flowed through that problematic vein is naturally redirected into nearby healthy veins.

There are two main forms of this treatment: liquid sclerotherapy and foam sclerotherapy.

• In standard (liquid) sclerotherapy, the sclerosant is injected as a clear liquid. This is commonly used for very small spider veins and short segments of reticular veins.
• In foam sclerotherapy, the sclerosant is mixed with air or gas to create a fine foam before injection. The foam displaces blood more effectively and remains in contact with the vein wall for longer, which increases its effect. Foam is especially helpful for slightly larger, tortuous, or deeper veins that a laser fibre cannot safely or easily navigate, or when treating residual segments that are not suitable for EVLA. Ultrasound guidance is often used for foam in larger or deeper veins to ensure accurate and safe placement of the sclerosant.

From the patient’s perspective, sclerotherapy is typically an outpatient procedure. The skin over the vein is cleaned, and the doctor injects the sclerosant using a very fine needle; many people describe the sensation as similar to a small ant bite or pinprick. Several veins can usually be treated in the same session, with multiple small injections along their course. Depending on the pattern and extent of veins, more than one session may be necessary, spaced weeks apart. After treatment, a compression stocking or bandage may be advised for a short period to improve vein closure and reduce the risk of complications.

Sclerotherapy is primarily aimed at improving the appearance of the legs and relieving local symptoms related to small veins (such as burning, itching, or mild discomfort around spider veins). However, its long-term success is strongly influenced by the pressure within the venous system. If there is significant untreated reflux in a major trunk vein, the high pressure will continue to push blood into surface veins, and new spider veins or small varicose veins are more likely to appear over time. For this reason, in a leg with proven valve failure in a main vein, sclerotherapy alone is generally considered incomplete treatment; it works best when used after the root cause (trunk reflux) has been treated, as part of a planned, stepwise approach.

4. EVLA vs. Sclerotherapy – A Simple Comparison

Once the basic concepts are clear, it helps to see EVLA and sclerotherapy side by side. They are not rival treatments; they are different tools used at different levels of the same problem.

Here is an easy comparison:

Feature	EVLA (Endovenous Laser Ablation)	Sclerotherapy (Injection Treatment)
Target veins	Large, bulging varicose veins; main “trunk” veins (e.g. great saphenous vein)	Small spider veins, reticular (blue/green) veins, and leftover side branches
Primary purpose	Medical: treats abnormal blood flow and high pressure (reflux)	Mainly cosmetic: improves the appearance of the skin and fine veins
Anesthesia	Local anaesthesia (often with tumescent fluid around the vein)	Usually none; sometimes local cooling or topical anaesthetic if needed
Downtime	Walk immediately after; light activities allowed, compression stockings worn	Walk immediately after; usually no real “downtime”, may also use compression stockings
Permanence	High success rates reported (often >90–95% vein closure with proper technique and follow-up)	Often needs repeat or maintenance sessions over time, especially if underlying reflux persists

Now, a bit more detail behind each line of the chart:

• Target veins:
  EVLA is designed for larger, straighter superficial veins that show significant valve failure and reflux on Doppler ultrasound. These are usually the “root cause” veins driving the problem. Sclerotherapy, by contrast, targets surface-level veins: fine red spider veins, small blue/green reticular veins, and residual side branches that remain once the main trunk has been dealt with.
• Primary purpose:
  EVLA is primarily a medical treatment. It changes the abnormal blood flow pattern by closing the diseased vein, thereby reducing venous hypertension (high pressure) in the limb. This can improve symptoms such as heaviness, swelling, aching, skin changes, and risk of ulceration.
  Sclerotherapy is largely cosmetic or finishing – it makes the leg look clearer by removing visible small veins. It can also relieve local discomfort around these veins, but it does not usually solve the underlying reflux if a major trunk vein is incompetent.
• Anaesthesia:
  EVLA typically requires local anaesthesia, often in the form of tumescent solution infiltrated around the vein. This provides pain relief, compresses the vein, and protects surrounding tissues from heat.
  Sclerotherapy usually does not need injected anaesthesia; the sclerosant is given through very fine needles, and most patients tolerate it with only mild stinging or burning. For very sensitive areas or patients, topical numbing cream or cooling may be used.
• Downtime and recovery:
  Both treatments are walk-in, walk-out procedures in most modern settings. After ELVA, patients are encouraged to walk immediately and to wear compression stockings for a recommended period; heavy exercise is restricted for a short time. After sclerotherapy, walking is also encouraged, and compression is often advised because it helps the treated veins close properly and reduces side effects such as bruising or pigmentation. In both cases, most patients can continue normal daily activities with minimal interruption.
• Permanence and need for repeat sessions:
  EVLA, when performed correctly on a suitable vein, has high closure and long-term success rates in published studies, often above 90–95% for the treated trunk. Once that main vein is closed and permanently fibrosed, it rarely reopens.
  Sclerotherapy, on the other hand, often requires multiple sessions to clear a network of small veins, and new spider veins can appear over time, especially if the person has an ongoing tendency to vein disease, hormonal factors, or if deeper reflux has not been addressed. It is therefore common to think of sclerotherapy as a treatment that may need periodic “maintenance”, whereas ELVA is aimed at a more definitive correction of a specific diseased vein.

Put simply: EVLA fixes the faulty “pipe” that is causing the pressure problem, while sclerotherapy clears the visible effects on the surface. Both have important roles, but they are rarely interchangeable.

5. The “Combo” Approach: Why Many Legs Need Both

Once the difference between EVLA and sclerotherapy is clear, the next logical question is: “So which one do I actually need?” In real-life practice, many patients do not fall neatly into a “laser only” or “injections only” category. Instead, they benefit most from a planned combination – first correcting the underlying reflux in the main vein, then refining the cosmetic appearance with injections.

A modern vein-treatment pathway usually begins with a detailed ultrasound Colour Doppler scan. This is not just a quick look; it is a functional test that shows:

• Which veins are dilated
• Where the valves are leaking (sites of reflux)
• How severe the reflux is
• How blood is flowing through both the superficial and deep systems

Based on this map, the doctor can distinguish between “source veins” (trunk veins causing high pressure) and “surface veins” (spider and reticular veins that are mainly cosmetic). This step is crucial. Without it, any decision between ELVA and sclerotherapy is essentially guesswork.

If the scan shows significant valve failure in a main superficial trunk vein such as the great saphenous vein, the usual first step is Endovenous Laser Ablation (EVLA). In this stage, the diseased “highway” vein that is allowing blood to fall back down the leg is closed from the inside. By eliminating this major source of reflux, the pressure within the network of surface veins is reduced. Some of the visible veins may flatten or improve on their own over the following weeks simply because the abnormal pressure has been taken away.

After this, attention can turn to the cosmetic detail. Even when ELVA is successful, many people still have residual small varicose veins, reticular veins, and spider veins that do not vanish completely. At this point, sclerotherapy is used as a second step – often scheduled several weeks after EVLA, once the leg has settled and the full effect of the pressure reduction can be seen. The sclerosant injections then target the remaining visible veins, “cleaning up” the surface and creating a more uniform appearance. In some patients, more than one sclerotherapy session may be needed, depending on how extensive the network of small veins is.

The key principle behind this sequence is simple:

Treat the cause first, then the consequence.

If significant trunk reflux is present and only sclerotherapy is performed on surface veins, the underlying high-pressure flow remains unchanged. The injected veins may initially close, but ongoing reflux tends to promote the formation of new abnormal veins over time. In practical terms, doing sclerotherapy alone on a leg with untreated valve failure often leads to short-lived results and repeated procedures. It is not that sclerotherapy is ineffective – it is very effective for the right veins – but that it is being used without addressing the driving force behind the problem.

Therefore, the most rational and medically sound strategy in many cases is a combination approach:

1. Step 1 – Colour Doppler mapping: Identify which veins are truly responsible for the problem.
2. Step 2 – EVLA: Close the main leaking “highway” vein to control reflux and venous hypertension.
3. Step 3 – Sclerotherapy: Once the system is decompressed, clear the remaining small and superficial veins for an optimal cosmetic and symptomatic result.

This structured sequence respects both medical correctness (treating disease and preventing progression) and patient expectations (wanting legs that not only feel better but also look better).

6. Conclusion

Choosing between EVLA/ELVA and sclerotherapy is not something you should have to guess. The veins visible on the surface rarely tell the full story; what matters medically is whether there is underlying valve failure and reflux in a main trunk vein. ELVA is designed to treat that root cause by closing the faulty vein and reducing abnormal venous pressure. Sclerotherapy is then used to target the remaining small and medium veins on the surface for a better cosmetic result. In many patients, the most effective plan is a combination of both treatments, performed in the right order.

The correct starting point is not the procedure – it is the Colour Doppler venous scan. This ultrasound-based test maps your veins, shows which valves are leaking, and clarifies whether your problem is purely cosmetic or part of a deeper circulation issue. Only after this scan can a responsible, medically sound decision be made about EVLA, sclerotherapy, or a combination of the two.

If you are unsure which treatment is appropriate for your legs, the next step is simple:
book a detailed Colour Doppler evaluation at our clinic in Delhi.

You can reach the clinic here:

• 🌐 Website: https://drparulgarg.com
• 📞 Phone / WhatsApp: +91-9211978100
• 📧 Email: [email protected]

During your visit, your veins will be properly mapped, the presence or absence of reflux will be documented, and you’ll receive a clear explanation of whether your problem is skin-deep or deeper within – and which combination of ELVA and sclerotherapy, if any, is truly appropriate for you.